Improved health-related quality of life using a mindfulness app for kidney cancer patients
Randomised clinical trials have previously shown the benefit of mindfulness [...]
Quality of life reporting in kidney cancer clinical trials
Quality-of-life (QoL) is very important to patients when they are [...]
Health-related quality of life with lenvatinib in combination with everolimus
Maintaining good health-related quality of life is important for all [...]
Quality of life on lenvatinib plus pembrolizumab combination
In this study, the health-related quality of life (HRQoL) of [...]
EIKCS 2022: Care for the whole patient
At the 2022 European International Kidney Cancer Symposium (EIKCS) in [...]
ESMO 2021: Pembrolizumab as adjuvant therapy
Adjuvant therapy is medication that is given in addition to [...]
Health-related quality of life for kidney cancer patients on pembrolizumab/lenvatinib
In this video, Dr Bradley McGregor from the Dana-Farber Cancer [...]
ASCO 2021: Health-related quality of life for lenvatinib plus pembrolizumab for advanced kidney cancer
Results from the phase 3 CLEAR study were presented at [...]
Quality versus quantity of life with cabozantinib and sunitinib in advanced kidney cancer
Cabozantinib and sunitinib are both drugs that block the development [...]
ESMO Virtual 2020: Quality of life impact of immune checkpoint inhibitors
Immune checkpoint inhibitors have changed the way renal cell carcinoma [...]
